Regulus’ microRNA wins potential $750m Sanofi deal
Regulus Therapeutics’ microRNA satellite technology has won the firm its biggest deal to date with French drugmaker Sanofi-Aventis agreeing a development accord worth up to $750m (€606m).
Archives for June 27, 2010
New York group aims to speed recruitment with e-records
A US group representing hospitals in New York wants to accelerate clinical research process by improving trial access to electronic patient records, while maintaining patient privacy.
Appointments at DPT, PPD, ACR Image Metrix, NexMed, ResearchPoint, CEDRA, Chemspec and Covance – People on the move
Outsourcing-Pharma presents its latest round up of movements in the pharma outsourcing space, including appointments at DPT, PPD, ACR Image Metrix, NexMed, ResearchPoint, CEDRA, Chemspec and Covance.
Gilead buys a $120m ticket for protein kinase research role
A deal to broaden Gilead’s research expertise into protein kinase biology has been finalised with the $120m acquisition of CGI Pharmaceuticals, in a deal that compliments its comprehensive selection of anti-HIV treatments.
Gerresheimer chief wants more global expansion
New Gerresheimer CEO Uwe Roehrhoff wants the German firm to become the pharmaceutical and biopharmaceutical industry “first choice” partner for high-tech packaging.
TRL refocuses new US site on biologic drugs
Tanabe Research Labs (TRL) has revealed details of its new San Diego facility in which the revised layout of the site allows a fresh focus on antibody and biological approaches to autoimmune diseases such as diabetes and rheumatoid arthritis.